Kalif Eliyahu Sharon Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$2.85M

Insider Activity of Kalif Eliyahu Sharon

According to the SEC Form 4 filings, Kalif Eliyahu Sharon, being in a position of

  1. EVP, Chief Financial Officer at Teva Pharmaceutical Industries Limited,
    оver the last 12 months, has bought 0 shares, and sold 605624 shares for $20.73M,
    over all time since 2022-08-22, has bought 0 shares, and sold 885324 shares for $24.53M.

Biography of Kalif Eliyahu Sharon

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$20,725,3923100

Comparison of Insiders on Amount of Buys and Sells

2026-06-11SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Chief Financial Officer
106,563
0.009%
$34.10$3.63M+6.13%
2026-05-14SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Chief Financial Officer
153,251
0.0133%
$35.61$5.46M+2.35%
2026-02-26SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Chief Financial Officer
345,810
0.03%
$33.64$11.63M+2.34%
2025-06-12SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Chief Financial Officer
55,775
0.0047%
$17.08$952,464+61.32%
2025-02-28SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Chief Financial Officer
55,750
0.0048%
$16.21$903,462+11.51%
2024-03-06SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Chief Financial Officer
77,550
0.0069%
$13.52$1.05M+25.98%
2023-08-07SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Chief Financial Officer
35,125
0.0032%
$9.73$341,889+27.36%
2022-08-22SaleTeva Pharmaceutical Industries Limited
TEVA
EVP, Chief Financial Officer
55,500
0.0049%
$10.07$558,696-13.68%
Total: 8
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.